Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P774: Higher plasma cotinine is associated with an increased risk for later developing IBD, especially among users of combusted tobacco

ECCO '19 Copenhagen

Year: 2019
Authors:

L. Widbom*1, J. Schneede2, P. Karling3, J. Hultdin1

1Umeå University, Department of medical bioscienses, clinical chemistry, Umeå, Sweden, 2Umeå University, Department of pharmacology and clinical neuroscience, Umeå, Sweden, 3Umeå University, Department of public health and clinical medicine, Umeå, Sweden

P775: Finger clubbing and Crohn's disease: higher frequency in patients with upper GI lesions in a prospective study

ECCO '19 Copenhagen

Year: 2019
Authors:

S. Romeo1, B. Neri*1, E. Lolli1, E. Calabrese1, E. De Cristofaro1, C. Gesuale1, L. Biancone1

1University of Rome 'Tor Vergata', Gastroenterology, Rome, Italy

P776: Factors associated with quality of care perceived by patients in IBD units from Spain. Analysis from IQCARO project

ECCO '19 Copenhagen

Year: 2019
Authors:

F. Casellas1, D. Carpio2, M. Minguez3, I. Vera4, B. Juliá*5, L. Marin6, R. Saldaña7, L. Cea5, X. Calvet8

1Hospital Vall d′Hebron, Gastroenterology Department, Barcelona, Spain, 2Complejo Hospitalario de Pontevedra, Gastroenterology Unit, Pontevedra, Spain, 3Hospital Clínico Universitario, Unidad de Gastroenterología, Valencia, Spain, 4Hospital Universitario Puerta de Hierro, Servicio de Gastroenterologia, Madrid, Spain, 5Medical Department, MSD, Madrid, Spain, 6Hospital Universitari Germans Trias i Pujol, Gastroenterology Unit, Badalona, Spain, 7Spanish Association of patients with Crohn′s disease and Ulcerative colitis, Madrid, Spain, 8Institut Universitari Parc Taulí, Digestive Unit, Sabadell, Spain

P777: The cancer incidence in paediatric onset inflammatory bowel disease: a population-based study from Denmark

ECCO '19 Copenhagen

Year: 2019
Authors:

M. Malham*1, C. Jakobsen1,2, A. Paerregaard1, L. B. Riis3, K-L. Kolho4, V. Wewer1

1Hvidovre University Hospital, The Paediatric Department, Hvidovre, Denmark, 2Hvidovre University Hospital, The GastroUnit, Hvidovre, Denmark, 3Herlev Hospital, The Department of Pathology, Herlev, Denmark, 4Tampere University Hospital, The Paediatric Department, Tampere, Finland

P778: Risk of cancer in paediatric onset inflammatory bowel disease: a nationwide cohort study 1977–2014

ECCO '19 Copenhagen

Year: 2019
Authors:

V. S. Kjærgaard1,2, C. B. Jensen1, J. Burisch1,3, K. Allin1, T. Jess*1

1Bispebjerg and Frederiksberg Hospital, Center for Clinical Research and Prevention, Copenhagen, Denmark, 2University of Glasgow, Glasgow, UK, 3Bispebjerg and Frederiksberg Hospital, Abdominal Centre K, Copenhagen, Denmark

P779: Extra intestinal manifestations and other comorbidities in Crohn’s disease and Ulcerative colitis are equally likely to appear before IBD diagnosis: a Danish nationwide registry study from 2003 to 2015

ECCO '19 Copenhagen

Year: 2019
Authors:

K. Vadstrup*1, S. Alulis1, A. Borsi2, T. R. Jørgensen3, A. Nielsen4, P. Munkholm5, N. Qvist6

1Janssen Immunology, Birkerød, Denmark, 2Janssen Immunology, High Wycombe, UK, 3Leo Pharma, Ballerup, Denmark, 4Incentive, Holte, Denmark, 5North Zealand University Hospital, Frederikssund, Denmark, 6Odense University Hospital, Odense, Denmark

P780: Medical treatment and surgery in patients with elderly-onset inflammatory bowel disease: 3-year follow-up of Epi-IBD 2010–2011 cohorts

ECCO '19 Copenhagen

Year: 2019
Authors:

V. Hernandez*1, J. Martinez-Cadilla1, E. Langholz2, D. Christodoulou3, S. Turcan4, D. Valpiani5, P. L. Lakatos6, Z. Vegh6, A. Goldis7, E. Belousova8, K. Ladefoged9, G. Kiudelis10, D. McNamara11, O. Shonova12, Z. Krznarić13, F. Magro14, E. S. Bjornsson15, S. Almer16, M. Fumery17, D. Duricova18, A. Kievit19, I. Kaimakliotis20, P. Ellul21, O. Niewiadomski22, M. Giannotta23, S. Odes24, N. Pedersen25, J. F. Dahlerup26, J. F. Dahlerup26, R. Salupere27, R. D'Incà28, R. D'Incà28, J. Halfvarson29, P. Oksanen30, N. Arebi31, K. R. Nielsen32, V. Andersen33, S. Shaji34, P. Munkholm35, J. Burisch35, Epi-IBD-group1

1Instituto de Investigación Sanitaria Galicia Sur. Hospital Alvaro Cunqueiro. EOXI Vigo, Gastroenterology, Vigo, Spain, 2Gentofte Hospital, Medical Gastroenterology, Copenhagen, Denmark, 3University Hospital Ioannina, 1st Division of Internal Medicine and Hepato-Gastroenterology Unit, Ioannina, Greece, 4State University of Medicine and Pharmacy of the Republic of Moldova, Gastroenterology, Chisinau, Moldova, Republic of, 5Morgagni Hospital, Gastroenterology and Digestive Endoscopy, Forli, Italy, 6Semmelweis University, 1st Department of Medicine, Budapest, Hungary, 7University of Medicine ‘Victor Babes’, Clinic of Gastroenterology, Timisoara, Romania, 8Moscow Regional Research Clinical Institute, Gastroenterology, Moscow, Russian Federation, 9Dronning Ingrids Hospital, Medical Department, Nuuk, Greenland, 10Lithuanian University of Health Sciences, Institute for Digestive Research, Kaunas, Lithuania, 11Adelaide and Meath Hospital, Gastroenterology, Dublin, Ireland, 12Hospital Ceské Budejovice, Gastroenterology, Ceské Budejovice, Czech Republic, 13University Hospital Center Zagreb, Gastroenterology, Zagreb, Croatia, 14Hospital de São João, Porto; Institute of Pharmacology and Therapeutics, Oporto Medical School and Institute for molecular and cell biology, Gastroenterology, Porto, Portugal, 1521Landspitali - The National University Hospital of Iceland, Gastroenterology, Reykjavik, Iceland, 16Karolinska Institutet, GastroCentrum, Stockholm, Sweden, 17Amiens University and Hospital, Epimad Registry, Gastroenterology Unit, Amiens, France, 18Charles University, IBD Center ISCARE, Prague, Czech Republic, 19Herning Central Hospital, Medicine, Herning, Denmark, 20Private Practice, Nicosia, Cyprus, 21Mater Dei Hospital, Gastroenterology, Msida, Malta, 22St Vincent's Hospital, Gastroenterology, Melbourne, Australia, 23AOU Careggi Regional Referral Center for Inflammatory Bowel Disease, Gastroenterology, Florence, Italy, 24Soroka Medical Center and Ben Gurion University of the Negev, Gastroenterology and Hepatology, Beer Sheva, Israel, 25Slagelse Hospital, Gastroenterology, Slagelse, Denmark, 26Arhus University Hospital, Medicine V (Hepatology and Gastroenterology), Arhus, Denmark, 27Tartu University Hospital, Endocrinology and Gastroenterology, Tartu, Estonia, 28Azienda Ospedaliera di Padova, Surgery, Oncology and Gastroenterology, Padova, Italy, 29Faculty of Medicine and Health, Gastroenterology, Orebro, Sweden, 30Tampere University Hospital, Gastroenterology and Alimentary Tract Surgery, Tampere, Finland, 31St. Mark's Hospital, Imperial College London, Gastroenterology, London, UK, 32The National Hospital of the Faroe Islands, Medical Department, Torshavn, Faroe Islands, 33Regional Hospital of Viborg, Medical Department, Viborg, Denmark, 34Hull and East Yorkshire NHS Trust, IBD Unit, Hull, UK, 35North Zealand University Hospital, Gastroenterology, Frederikssund, Denmark

P781: Defining the economic burden of venous thromboembolism after surgery for inflammatory bowel disease in the USA: a national inpatient sample study

ECCO '19 Copenhagen

Year: 2019
Authors:

C. H. A. Lee1, A. Aiello2, L. Stocchi1, J. Lipman1, S. Shawki1, T. Hull1, S. Steele1, S. Holubar*1

1Cleveland Clinic, Colon and Rectal Surgery, Cleveland, USA, 2Cleveland Clinic, Quantitative Health Sciences, Cleveland, USA

P782: Living with ulcerative colitis in Germany: quantifying the healthcare resource utilisation and direct healthcare costs associated with the treatment of moderate to severe ulcerative colitis in Germany

ECCO '19 Copenhagen

Year: 2019
Authors:

A. Dignass*1, J. Waller2, J. C. Cappelleri3, L. Salese4, A. Kisser5, L. Dietz5, M. DiBonaventura6, R. Wood2, D. Bargo6

1Agaplesion Markus Hospital, Frankfurt/Main, Germany, 2Adelphi Real World, Bollington, UK, 3Pfizer Inc., Groton, CT, USA, 4Pfizer Inc., Collegeville, PA, USA, 5Pfizer Germany GmbH, Berlin, Germany, 6Pfizer Inc., New York, NY, USA

P783: Long-term colectomy rate in acute severe ulcerative colitis. An observational multi-centre study on behalf of IG-IBD (Italian group for the study of inflammatory bowel disease)

ECCO '19 Copenhagen

Year: 2019
Authors:

S. Festa*1, M. L. Scribano2, D. Pugliese3, E. Sarli4, C. Bezzio5, M. B. Principi6, D. G. Ribaldone7, M. Allocca8, G. Mocci9, G. Bodini10, R. Spagnuolo11, P. Vernia12, S. Mazzuoli13, G. Laino14, B. Barberio15, G. Zerboni16, A. Aratari16, C. Papi16

1Ospedale San Filippo Neri, IBD Unit, Roma, Italy, 2UOC Gastroenterologia ed Endoscopia Digestiva Diagnostica e Operativa A.O. San Camillo-Forlanini, Roma, Italy, 3IBD Unit, Presidio Columbus Fondazione Policlinico Universitario A. Gemelli IRCCS Università Cattolica, Rome, Italy, 4Statistician - Italian Group for the study of Inflammatory Bowel Disease, Firenze, Italy, 5U.O. Gastroenterologia, Ospedale di Rho, ASST Rhodense, Rho (Milano), Italy, 6Sezione di Gastroenterologia, Azienda Policlinico Universitaria Bari, Bari, Italy, 7Department of Surgical Sciences, University of Turin, Torino, Italy, 8IBD Centre, Humanitas Clinical and Research Centre; *Department of Biomedical Sciences, Humanitas University, Rozzano (Milano), Italy, 9SC Gastroenterologia Ospedale Brotzu, Cagliari, Italy, 10University of Genoa, Policlinico San Martino Department of internal medicine, Genova, Italy, 11UOC Gastroenterologia AOU Mater Domini, Catanzaro, Italy, 12Divisione di Gastroenterologia, Dipartimento di Medicina Interna e Specialità Mediche, Sapienza Università di Roma, Roma, Italy, 13UOC Gastroenterologia Ospedale San Nicola Pellegrino, Trani, Italy, 14Department of New Technologies and Translational Research in Medicine and Surgery, University of Pisa, Pisa, Italy, 15Dipartimento di scienze chirurgiche, oncologiche e gastroenterologiche Università di Padova, Padova, Italy, 16Ospedale S. Filippo Neri, IBD Unit, Roma, Italy

P784: Prevalence of cervical dysplasia in women with inflammatory bowel disease: data from the Parelsnoer Institute (PSI) and PALGA database (PAP-IBD study)

ECCO '19 Copenhagen

Year: 2019
Authors:

R. Goetgebuer*1, J. Kreijne1, C. Aitken2, M. Pierik3, F. Hoentjen4, N. de Boer5, B. Oldenburg6, A. van der Meulen7, C. Ponsioen8, G. Dijkstra9, F. van Kemenade10, G. Nieuwenhuyzen – de Boer11, A. Siebers12, C. J. van der Woude1, A. de Vries1

1Erasmus MC, University Medical Center, Gastroenterology and hepatology, Rotterdam, The Netherlands, 2Erasmus MC, University Medical Center, Public Health, Rotterdam, The Netherlands, 3Maastricht University Medical Center, Gastroenterology and Hepatology, Maastricht, The Netherlands, 4Radboud University Medical Center, Gastroenterology and Hepatology, Nijmegen, The Netherlands, 5VU University Medical Center, Gastroenterology and Hepatology, Amsterdam, The Netherlands, 6University Medical Center Utrecht, Gastroenterology and Hepatology, Utrecht, The Netherlands, 7Leiden University Medical Center, Gastroenterology and Hepatology, Leiden, The Netherlands, 8Academic Medical Center, Gastroenterology and Hepatology, Amsterdam, The Netherlands, 9University Medical Center Groningen, Gastroenterology and Hepatology, Groningen, The Netherlands, 10Erasmus MC, University Medical Center, Pathology, Rotterdam, The Netherlands, 11Erasmus MC, University Medical Center, Gynaecologic Oncology, Rotterdam, The Netherlands, 12PALGA, the nationwide network and registry of histo- and cytopathology in the Netherlands, Houten, The Netherlands

P785: The prevalence of inflammatory bowel disease doubled in the last decade in Israel: an epiIIRN national population-based study

ECCO '19 Copenhagen

Year: 2019
Authors:

M. Friedman1,2, D. Navon1, N. Asayag1, G. Focht1, I. Brufman3, B. Feldman3, A. Cahan4, N. Ledderman5, E. Matz6, Y. Chowers7, R. Eliakim8, S. Ben-Horin8, S. Odes9, D. Schwartz9, I. Dotan10, E. Israeli11, R. D. Balicer3, D. Turner*1, Israeli IBD Research Nucleus (IIRN)1

1Shaare Zedek Medical Center, The Juliet Keidan Institute of Paediatric Gastroenterology and Nutrition, Jerusalem, Israel, 2The Hebrew University- Hadassah Medical Center, Braun School of Public and Community Medicine, Jerusalem, Israel, 3Clalit Health Services, Clalit Research Institute, Chief’s Office, Tel Aviv, Israel, 4Maccabi Healthcare Services, Tel Aviv, Israel, 5Meuhedet Health Services, Tel Aviv, Israel, 6Leumit Health Services, Tel Aviv, Israel, 7Rambam Health Care Campus, Department of Gastroenterology, Haifa, Israel, 8Chaim Sheba Medical Center, Department of Gastroenterology, Tel Hashomer, Israel, 9Faculty of Health Sciences,Ben-Gurion University of the Negev, Department of Gastroenterology and Hepatology, Beer Sheva, Israel, 10Rabin Medical Center, Division of Gastroenterology, Petah Tivka, Israel, 11Hadassah Medical Center, Hebrew University, Institute of Gastroenterology and Liver Diseases, Jerusalem, Israel

P786: Mode of delivery and risk of inflammatory bowel disease

ECCO '19 Copenhagen

Year: 2019
Authors:

C. Frias Gomes*1, N. Narula2, B. Morão1, P. Nicola3, M. Cravo1, J. Torres1

1Hospital Beatriz Ângelo, Gastroenterology, Loures, Portugal, 2Farncombe Family Digestive Health Research Institute, Ontario, Canada, 3Faculty of Medicina of Lisbon, Lisboa, Portugal

P787: Vitamin D status and clinical outcomes in inflammatory bowel disease patients: a systematic review and meta-analysis

ECCO '19 Copenhagen

Year: 2019
Authors:

J. M. Gubatan*1,2, N. D. Chou1, O. H. Nielsen3, A. C. Moss1

1Beth Israel Deaconess Medical Center, Harvard Medical School, Division of Gastroenterology and Hepatology, Boston, USA, 2Stanford University School of Medicine, Division of Gastroenterology and Hepatology, Stanford, USA, 3Herlev Hospital, University of Copenhagen, Department of Gastroenterology, Copenhagen, Denmark

P788: Risks and predictors of osteoporosis in inflammatory bowel diseases: a nationwide Korean population-based cohort study

ECCO '19 Copenhagen

Year: 2019
Authors:

T. J. Kim*1, S. M. Kong1, J. B. Shin1, E. R. Kim1, S. N. Hong1, D. K. Chang1, Y-H. Kim1

1Samsung Medical Center, Seoul, South Korea

P789: Symptom burden and lack of remission among adult patients with ulcerative colitis (UC): retrospective analysis of cross-sectional survey data from the US and Germany

ECCO '19 Copenhagen

Year: 2019
Authors:

B. Gorsh*1, M. Bracher2, J. M. Symons1, B. Nafees2, D. Chauhan2, B. Hoskin3, J. Lucas3, J. Kershaw3, C. Middleton3

1GlaxoSmithKline, Value Evidence and Outcomes, Collegeville, USA, 2GlaxoSmithKline, Value Evidence and Outcomes, Stevenage, UK, 3Adelphi Real World, Macclesfield, UK

P790: Epidemiology, clinical characteristics, evolution and treatments in newly diagnosed inflammatory bowel disease (IBD): results from the nationwide EpidemIBD study of GETECCU

ECCO '19 Copenhagen

Year: 2019
Authors:

M. Chaparro*1, M. Barreiro-de Acosta2, J. Benítez3, J. Cabriada4, M. Casanova1, D. Ceballos5, M. Esteve6, H. Fernández7, D. Ginard8, F. Gomollón9, R. Lorente10, P. Nos11, S. Riestra12, M. Rivero13, P. Robledo14, C. Rodríguez15, B. Sicilia16, E. Torrella17, A. Garre1, F. Rodríguez-Artalejo18, E. García-Esquinas18, J. Gisbert1, EpidemIBD group1

1Hospital Universitario de La Princesa, ISS-IP, Universidad Autónoma de Madrid and CIBEREHD, Gastroenterology Unit, Madrid, Spain, 2Hospital Universitario Clínico de Santiago, Gastroenterology Unit, Santiago de Compostela, Spain, 3Hospital Universitario Reina Sofía and IMIBIC, Gastroenterology Unit, Córdoba, Spain, 4Hospital Universitario de Galdakao, Gastroenterology Unit, Galdakao, Spain, 5Hospital Universitario de Gran Canaria Doctor Negrín, Gastroenterology Unit, Las Palmas de Gran Canaria, Spain, 6Mutua Terrasa, Gastroenterology Unit, Tarrasa, Spain, 7Hospital San Pedro, Gastroenterology Unit, Logroño, Spain, 8Hospital Universitario Son Espases, Gastroenterology Unit, Palma de Mallorca, Spain, 9Hospital Lozano Blesa, IIS Aragón and CIBERehd, Gastroenterology Unit, Zaragoza, Spain, 10Hospital General Universitario de Ciudad Real, Gastroenterology Unit, Ciudad Real, Spain, 11Hospital Universitario y Politécnico de La Fe and CIBEREHD, Gastroenterology Unit, Valencia, Spain, 12Hospital Universitario Central de Asturias, Gastroenterology Unit, Oviedo, Spain, 13Hospital Universitario Marqués de Valdecilla, Gastroenterology Unit, Santander, Spain, 14Hospital San Pedro de Alcántara, Gastroenterology Unit, Cáceres, Spain, 15Complejo Hospitalario de Navarra, Gastroenterology Unit, Pamplona, Spain, 16Hospital Universitario de Burgos, Gastroenterology Unit, Burgos, Spain, 17Hospital General Universitario Morales Meseguer, Gastroenterology Unit, Murcia, Spain, 18Universidad Autónoma de Madrid/IdiPaz and CIBERESP, Department of Preventive Medicine and Public Health, Madrid, Spain

P791: Influence of patients’ preference in randomised controlled trials

ECCO '19 Copenhagen

Year: 2019
Authors:

K. Wasmann*1, P. Wijsman2, S. van Dieren3, W. Bemelman4, C. Buskens4

1Amsterdam UMC, Department of Surgery and Gastroenterology, Amsterdam, The Netherlands, 2Spaarne Gasthuis, Department of Internal medicine, Hoofddorp, The Netherlands, 3Amsterdam UMC, Clinical Research Unit, Amsterdam, The Netherlands, 4Amsterdam UMC, Department of Surgery, Amsterdam, The Netherlands

P792: Phenotype and natural history of inflammatory bowel disease: results from the largest centre in Singapore

ECCO '19 Copenhagen

Year: 2019
Authors:

W. P. W. Chan*1,2, M. S. Lim1, A. X. H. Tan1, K. Chen1, A. T. M. Gan1, T. G. Lim1, W. C. Ong1, S. C. Kong3, H. H. Shim1

1Singapore General Hospital, Gastroenterology, Singapore, Singapore, 2Duke-NUS Medical School, Singapore, Singapore, 3SengKang General Hospital, Singapore, Singapore

P793: The cost burden of Crohn’s disease and ulcerative colitis dependent on biologic treatment status – a register-based Danish population study from 2003 to 2015

ECCO '19 Copenhagen

Year: 2019
Authors:

S. Alulis1, K. Vadstrup*1, A. Borsi2, N. Gustafsson3, T. R. Jørgensen4, P. Munkholm5, N. Qvist6

1Janssen Immunology, Birkerød, Denmark, 2Janssen Immunology, High Wycombe, UK, 3Incentive, Holte, Denmark, 4Leo Pharma, Ballerup, Denmark, 5North Zealand University Hospital, Frederikssund, Denmark, 6Odense University Hospital, Odense, Denmark